347 250 (Cefprozil 250 mg)

Pill imprint 347 250 has been identified as Cefprozil 250 mg.

Cefprozil is used in the treatment of bladder infection; otitis media; tonsillitis/pharyngitis; sinusitis; bronchitis (and more), and belongs to the drug class second generation cephalosporins. There is no proven risk in humans during pregnancy. Cefprozil 250 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for 347 250

Cefprozil 250 mg 347 250
Cefprozil
Imprint:
347
250
Strength:
250 mg
Color:
White
Size:
14.00 mm
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Second generation cephalosporins
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Sandoz Pharmaceuticals Inc.
National Drug Code (NDC):
00781-5043
Inactive Ingredients:
hypromelloses
magnesium stearate
methylcellulose (400 mPa.s)
microcrystalline cellulose
polyethylene glycol 400
polysorbate 80
sodium starch glycolate type A potato
titanium dioxide

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web3)